Thomas Jaquin is currently the Director of In Vivo Pharmacology and Discovery at Proteinea, where they lead efforts in advancing pharmacological research. Previously, they contributed to projects at Pieris Pharmaceuticals, serving in various senior roles, including Principal Scientist and Associate Director of Preclinical Assay Platform. Thomas began their career at Fusion Antibodies Ltd, where they evaluated cancer-specific targets and characterized novel therapeutic monoclonal antibodies. They also held the position of Senior Research Scientist in experimental oncology at Pierre Fabre, designing xenograft animal models to support cancer treatment evaluations. Thomas earned a Ph.D. in Cancer Research from Queen's University Belfast and a Master of Sciences in Biotechnology from ENSTBB Bordeaux INP.
This person is not in the org chart
This person is not in any teams
This person is not in any offices